Sandbox:Affan: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 175: | Line 175: | ||
|- | |- | ||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Appearance | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ||
Line 374: | Line 374: | ||
|- | |- | ||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Oral lesions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Appearance | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ||
Line 564: | Line 564: | ||
* [[Prodromal]] [[skin]] target lesions, bullae and [[ulcerations]] with irregular borders and [[inflammatory]] halos, bloody encrustations on the [[lips]] | * [[Prodromal]] [[skin]] target lesions, bullae and [[ulcerations]] with irregular borders and [[inflammatory]] halos, bloody encrustations on the [[lips]] | ||
| | | | ||
* Infections e.g. EBV, CMV herpes, and mycoplasma etc | |||
* Drugs e.g. sulfonamides, anticonvulsants etc | |||
| | | | ||
*[[Lips]] | *[[Lips]] | ||
Line 580: | Line 582: | ||
*[[Edema]] and inflammations of the [[gingiva]] are frequent clinical signs. Moreover, a salivary flow decrease can develop [[opportunistic infections]]. | *[[Edema]] and inflammations of the [[gingiva]] are frequent clinical signs. Moreover, a salivary flow decrease can develop [[opportunistic infections]]. | ||
| | | | ||
* Crohn's diseae | |||
| | | | ||
*[[Gingiva]] | *[[Gingiva]] | ||
Line 592: | Line 595: | ||
*[[Desquamative gingivitis]] as the most common presentation | *[[Desquamative gingivitis]] as the most common presentation | ||
| | | | ||
* Psoriasis | |||
* Parkinson's disease | |||
* Dementia | |||
* Certain drugs e.g. spironolactone, loop diuretics and neuroleptics | |||
* Malignancies e.g. breast cancer | |||
| | | | ||
* [[Gingiva]] | * [[Gingiva]] | ||
Line 621: | Line 629: | ||
{| class="wikitable" | {| class="wikitable" | ||
|+ | |+ | ||
! colspan=" | ! colspan="7" style="background:#4479BA; color: #FFFFFF;" align="center" + |Soft tissue oral lesions | ||
|- | |- | ||
! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Reactive lesions | ! colspan="2" rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Reactive lesions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Appearance | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Location | ||
!Microscopic | |||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
Line 632: | Line 641: | ||
| | | | ||
| | | | ||
| | |||
* | |||
| | | | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Fibrous hyperplasia | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Fibrous hyperplasia | ||
| | |||
| | | | ||
| | | | ||
Line 640: | Line 652: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucocele | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucocele | ||
| | |||
| | | | ||
| | | | ||
Line 647: | Line 660: | ||
| | | | ||
| | | | ||
| | |||
| | | | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Periodontal abscess | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Periodontal abscess | ||
| | |||
| | | | ||
| | | | ||
Line 655: | Line 670: | ||
|- | |- | ||
| colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Periapical abscess | | colspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Periapical abscess | ||
| | |||
| | | | ||
| | | | ||
Line 660: | Line 676: | ||
|- | |- | ||
! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Tumors | ! colspan="2" style="background:#4479BA; color: #FFFFFF;" align="center" + |Tumors | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Appearance | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Associated conditions | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + | | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Locations | ||
! | ! colspan="2" |Microscopic | ||
! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ! rowspan="1" style="background:#4479BA; color: #FFFFFF;" align="center" + |Image | ||
|- | |- | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Epithelial tumors | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Epithelial tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Squamous cell carcinoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Squamous cell carcinoma | ||
| | |||
| | | | ||
| | | | ||
Line 675: | Line 692: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Oral epithelial dysplasia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Oral epithelial dysplasia | ||
| | |||
| | | | ||
| | | | ||
Line 682: | Line 700: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Proliferative verrucous leukoplakia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Proliferative verrucous leukoplakia | ||
| | |||
| | | | ||
| | | | ||
Line 690: | Line 709: | ||
| rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Papillomas | | rowspan="3" style="background: #DCDCDC; padding: 5px; text-align: center;" |Papillomas | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Condyloma acuminatum | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Condyloma acuminatum | ||
| | |||
| | | | ||
| | | | ||
Line 697: | Line 717: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Verrucous vulgaris | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Verrucous vulgaris | ||
| | |||
| | | | ||
| | | | ||
Line 704: | Line 725: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Multifocal epithelial hyperplasia | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Multifocal epithelial hyperplasia | ||
| | |||
| | | | ||
| | | | ||
Line 712: | Line 734: | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Salivary type tumors | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Salivary type tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucoepidermoid carcinoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Mucoepidermoid carcinoma | ||
| | |||
| | | | ||
| | | | ||
Line 719: | Line 742: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Pleomorphic adenoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Pleomorphic adenoma | ||
| | |||
| | | | ||
| | | | ||
Line 727: | Line 751: | ||
| rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |Soft tissue and Neural tumors | | rowspan="8" style="background: #DCDCDC; padding: 5px; text-align: center;" |Soft tissue and Neural tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Granular cell tumor | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Granular cell tumor | ||
| | |||
| | | | ||
| | | | ||
Line 734: | Line 759: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Rhabdomyoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Rhabdomyoma | ||
| | |||
| | | | ||
| | | | ||
Line 741: | Line 767: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Lymphangioma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Lymphangioma | ||
| | |||
| | | | ||
| | | | ||
Line 748: | Line 775: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemangioma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Hemangioma | ||
| | |||
| | | | ||
| | | | ||
Line 755: | Line 783: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Schwannoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Schwannoma | ||
| | |||
| | | | ||
| | | | ||
Line 762: | Line 791: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Neurofibroma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Neurofibroma | ||
| | |||
| | | | ||
| | | | ||
Line 769: | Line 799: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Kaposi sarcoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Kaposi sarcoma | ||
| | |||
| | | | ||
| | | | ||
Line 776: | Line 807: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Myofibroblastic sarcoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Myofibroblastic sarcoma | ||
| | |||
| | | | ||
| | | | ||
Line 784: | Line 816: | ||
| rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hematolymphoid tumors | | rowspan="4" style="background: #DCDCDC; padding: 5px; text-align: center;" |Hematolymphoid tumors | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |CD-30 positive lymphoproliferative disorder | | style="background: #DCDCDC; padding: 5px; text-align: center;" |CD-30 positive lymphoproliferative disorder | ||
| | |||
| | | | ||
| | | | ||
Line 791: | Line 824: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Plasmablastic lymphoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Plasmablastic lymphoma | ||
| | |||
| | | | ||
| | | | ||
Line 798: | Line 832: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Langerhan cell histiocytosis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Langerhan cell histiocytosis | ||
| | |||
| | | | ||
| | | | ||
Line 805: | Line 840: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Extramedullary myeloid sarcoma | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Extramedullary myeloid sarcoma | ||
| | |||
| | | | ||
| | | | ||
Line 813: | Line 849: | ||
| rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tumors of uncertain histiogenesis | | rowspan="2" style="background: #DCDCDC; padding: 5px; text-align: center;" |Tumors of uncertain histiogenesis | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Congenital granular cell epulis | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Congenital granular cell epulis | ||
| | |||
| | | | ||
| | | | ||
Line 820: | Line 857: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Ectomesenchymal chondromyxoid tumor | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Ectomesenchymal chondromyxoid tumor | ||
| | |||
| | | | ||
| | | | ||
Line 829: | Line 867: | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Gingival cyst | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Gingival cyst | ||
| | | | ||
* Small red color swelling with the bluish tinge | |||
* Painless around 6 mm in diameter | |||
| | | | ||
| | |Canine and premolar region of the mandible and less frequently maxilla | ||
| | | colspan="2" |Cystic cavity lined with: | ||
* Non-keratinized epithelial lining with or without focal areas of acanthosis consisting of clear cells | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Lymphoepithelial cyst | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Oral Lymphoepithelial cyst (Branchial cleft cyst) | ||
| | | | ||
* Painless | |||
* White to yellow | |||
* Soft to firm | |||
* Less than 1 cm | |||
| | | | ||
* HIV | |||
| | | | ||
* Floor of the mouth | |||
* Laterla margin of the tongue | |||
| colspan="2" |Cystic cavity lined with: | |||
* Stratified squamous and/or pseudostratified columnar epithelium cells containing desquamative epithelial and inflammatory cells | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epidermoid cyst | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Epidermoid cyst | ||
| | |||
| | | | ||
| | | | ||
Line 846: | Line 896: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Thyroglossal tract cyst | | style="background: #DCDCDC; padding: 5px; text-align: center;" |Thyroglossal tract cyst | ||
| | |||
| | | | ||
| | | | ||
Line 855: | Line 906: | ||
| | | | ||
| | | | ||
| | |||
| | | | ||
|- | |- |
Revision as of 00:07, 12 February 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Muhammad Affan M.D.[2]
Surface oral lesions | |||||||
---|---|---|---|---|---|---|---|
Oral lesions | Appearance | Associated conditions | Location | Microscopic | Image | ||
White Lesions | Leukoedema |
|
|
|
|
||
Fordyce granules |
|
|
|
|
|||
Benign migratoy glossitis |
|
|
|
|
|||
Hairy tongue |
|
|
|
|
|||
Hairy leukoplakia |
White patches
|
|
|
|
|||
White sponge nevus |
|
|
|
||||
Lichen Planus |
|
|
|
|
|||
Frictional hyperkeratosis |
|
|
|
|
|||
Leukoplakia |
|
|
|
|
|||
Erythroplakia |
|
|
|
|
|||
Oral lesions | Appearance | Associated conditions | Location | Microscopic | Image | ||
Pigmented lesions |
|
|
|
|
|
||
|
|
|
|
||||
|
|
|
|||||
|
|
|
|
|
|||
|
|
|
|
|
|||
|
|
|
|
||||
|
|
|
|
||||
|
|
Intraorally |
|
||||
|
|
|
|
||||
|
|
|
|||||
|
|
|
|
||||
Oral lesions | Appearance | Associated conditions | Location | Microscopic | Image | ||
Vesicular/
Ulcerative |
Infections | Herpes simplex virusinfections |
|
|
|
||
Herpes zoster |
|
|
|
||||
Hand foot mouth disease |
|
|
|||||
Infectious mononucliosis |
|
||||||
Erosive lichen planus |
|
||||||
Pseudomembranous candidiasis |
|
||||||
Histoplasmosis |
|
|
|||||
Blastomycosis |
|
|
|||||
Coccidiodomycosis |
|
||||||
Autoimmune conditions | Pemphigus vulgaris |
|
|
||||
Mucous membrane pemphigoid (Cicatricial pemphigoid) |
|
||||||
Aphthous ulcer |
|
||||||
Erythema multiforme |
|
|
|||||
Sjogren's Syndrome |
Affects salivary and lacrimal glands
|
|
|||||
Bullous pemphigoid |
|
|
|||||
Idiopathic conditions | Allergic contact stomatitis |
|
|
||||
Irritant contact stomatitis |
Soft tissue oral lesions | |||||||
---|---|---|---|---|---|---|---|
Reactive lesions | Appearance | Associated conditions | Location | Microscopic | Image | ||
Inflammatory papillary hyperplasia |
|
||||||
Fibrous hyperplasia | |||||||
Mucocele | |||||||
Necrotizing sialometaplasia | |||||||
Periodontal abscess | |||||||
Periapical abscess | |||||||
Tumors | Appearance | Associated conditions | Locations | Microscopic | Image | ||
Epithelial tumors | Squamous cell carcinoma | ||||||
Oral epithelial dysplasia | |||||||
Proliferative verrucous leukoplakia | |||||||
Papillomas | Condyloma acuminatum | ||||||
Verrucous vulgaris | |||||||
Multifocal epithelial hyperplasia | |||||||
Salivary type tumors | Mucoepidermoid carcinoma | ||||||
Pleomorphic adenoma | |||||||
Soft tissue and Neural tumors | Granular cell tumor | ||||||
Rhabdomyoma | |||||||
Lymphangioma | |||||||
Hemangioma | |||||||
Schwannoma | |||||||
Neurofibroma | |||||||
Kaposi sarcoma | |||||||
Myofibroblastic sarcoma | |||||||
Hematolymphoid tumors | CD-30 positive lymphoproliferative disorder | ||||||
Plasmablastic lymphoma | |||||||
Langerhan cell histiocytosis | |||||||
Extramedullary myeloid sarcoma | |||||||
Tumors of uncertain histiogenesis | Congenital granular cell epulis | ||||||
Ectomesenchymal chondromyxoid tumor | |||||||
Cysts | Gingival cyst |
|
Canine and premolar region of the mandible and less frequently maxilla | Cystic cavity lined with:
| |||
Oral Lymphoepithelial cyst (Branchial cleft cyst) |
|
|
|
Cystic cavity lined with:
| |||
Epidermoid cyst | |||||||
Thyroglossal tract cyst | |||||||
Nasolabial cyst |